Skip to content

A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease

David Lee Fischman, Martin B. Leon, Donald S. Baim, Richard A. Schatz, Michael P. Savage, Ian M. Penn, Katherine M. Detre, Lisa Veltri, Donald R. Ricci, Masakiyo Nobuyoshi, MICHAEL W. CLEMAN, Richard R. Heuser, David G. Almond, Paul S. Teirstein, R. David Fish, Antonio Colombo, Jeffrey Brinker, Jeffrey W. Moses, Alex Shaknovich, John Winslow Hirshfeld, Stephen R. Bailey, Stephen G. Ellis, Randal C. Rake, Sheldon Goldberg

New England Journal of Medicine · 1994 · 4,273 citationsOpen access

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Fischman, D. L., Leon, M. B., Baim, D. S., Schatz, R. A., Savage, M. P., Penn, I. M., Detre, K. M., Veltri, L., Ricci, D. R., Nobuyoshi, M., CLEMAN, M. W., Heuser, R. R., Almond, D. G., Teirstein, P. S., Fish, R. D., Colombo, A., Brinker, J., Moses, J. W., Shaknovich, A., … Goldberg, S. (1994). A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. New England Journal of Medicine, 331(8), 496–501. https://doi.org/10.1056/nejm199408253310802

In text: (Fischman et al., 1994)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

BACKGROUND: Coronary-stent placement is a new technique in which a balloon-expandable, stainless-steel, slotted tube is implanted at the site of a coronary stenosis. The purpose of this study was to compare the effects of stent placement and standard balloon angioplasty on angiographically detected restenosis and clinical outcomes. METHODS: We randomly assigned 410 patients with symptomatic coronary disease to elective placement of a Palmaz-Schatz stent or to standard balloon angioplasty. Coronary angiography was performed at base line, immediately after the procedure, and six months later. RESULTS: The patients who underwent stenting had a higher rate of procedural success than those who underwent standard balloon angioplasty (96.1 percent vs. 89.6 percent, P = 0.011), a larger immediate increase in the diameter of the lumen (1.72 +/- 0.46 vs. 1.23 +/- 0.48 mm, P < 0.001), and a larger luminal diameter immediately after the procedure (2.49 +/- 0.43 vs. 1.99 +/- 0.47 mm, P < 0.001). At six months, the patients with stented lesions continued to have a larger luminal diameter (1.74 +/- 0.60 vs. 1.56 +/- 0.65 mm, P = 0.007) and a lower rate of restenosis (31.6 percent vs. 42.1 percent, P = 0.046) than those treated with balloon angioplasty. There were no coronary events (death; myocardial infarction; coronary-artery bypass surgery; vessel closure, including stent thrombosis; or repeated angioplasty) in 80.5 percent of the patients in the stent group and 76.2 percent of those in the angioplasty group (P = 0.16). Revascularization of the original target lesion because of recurrent myocardial ischemia was performed less frequently in the stent group than in the angioplasty group (10.2 percent vs. 15.4 percent, P = 0.06). CONCLUSIONS: In selected patients, placement of an intracoronary stent, as compared with balloon angioplasty, results in an improved rate of procedural success, a lower rate of angiographically detected restenosis, a similar rate of clinical events after six months, and a less frequent need for revascularization of the original coronary lesion.

  1. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study2004
  2. Tissue Plasminogen Activator for Acute Ischemic Stroke1995
  3. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation2017
  4. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association2019
  5. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.1986

Metadata from OpenAlex (CC0). Citations are generated from the published record.